Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04506086
Title Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Amgen
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
University of California Los Angeles RECRUITING Los Angeles California 90095 United States Details
University of California Irvine RECRUITING Orange California 92868-3201 United States Details
Mayo Clinic Florida TERMINATED Jacksonville Florida 32224 United States Details
Adventist Health System/Sunbelt, Inc d/b/a AdventHealth Orlando COMPLETED Orlando Florida 32804 United States Details
Advocate Lutheran General Hospital COMPLETED Park Ridge Illinois 60068 United States Details
University of Nebraska Medical Center RECRUITING Omaha Nebraska 68198 United States Details
Mount Sinai Hospital COMPLETED New York New York 10029 United States Details
University of Rochester Cancer Center RECRUITING Rochester New York 14642 United States Details
Wake Forest Baptist Comprehensive Cancer Research Center RECRUITING Winston-Salem North Carolina 27157 United States Details
Saint Francis Hospital, Inc RECRUITING Greenville South Carolina 29607 United States Details
University of Virginia Health System RECRUITING Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from for the field